市場調査レポート

商品コード

1762471

多血小板血漿（PRP）の世界市場：市場規模・シェア・動向、業界分析 (種類別・用途別・最終用途別・地域別)、将来予測 (2025年～2034年)

Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034

出版日: 2025年06月01日
発行: Polaris Market Research
ページ情報: 英文 113 Pages
納期: 即日から翌営業日

カスタマイズ可能

価格

PDF (Single User License)

USD 4,250 624,282円

レポートPDFを1名のみがご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Multi User License)

USD 5,250 771,172円

レポートPDFを20名様までご利用頂けるライセンスです。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

PDF (Enterprise License)

USD 6,250 918,062円

レポートPDFを同一企業の全世界の方にご利用頂けるライセンスです。ご利用人数に制限はありません。 PDF内のテキスト等のコピー＆ペーストは可能です。印刷したもののご利用はPDFのご利用範囲に準拠します。

価格表記: USDを日本円(税抜)に換算

本日の銀行送金レート: 1USD=146.89円

全表示
概要
図表
目次

概要

サンプル依頼リストに入れる

Polaris Market Research社の最新調査によると、世界の多血小板血漿（PRP）市場規模は2034年までに28億5,798万米ドルに達する見込みです。このレポートは、現在の市場力学を詳細に洞察し、将来の市場成長に関する分析を提供しています。

多血小板血漿（PRP）は、再生医療と治療分野の主要成分であり、組織修復と治癒のアプローチを大きく変えます。患者自身の血液に由来するPRPは、アレルギー反応のリスクの低減や回復時間の短縮など、従来の治療法に比べていくつかの利点があります。PRPの需要の高まりは、その安全性、有効性、自然治癒特性によって後押しされ、整形外科、皮膚科、スポーツ医学、医療美容の各分野でますます好まれる選択肢となっています。

PRP市場は、進行中の科学的進歩と現実の臨床現場での需要の増加により急速に拡大しています。世界の政府は、資金、研究助成金、有利な規制を通じて再生医療を支援しており、PRPベースの治療の開発と採用を奨励しています。したがって、これらの要因は、組織修復や筋骨格系の治癒などの分野におけるPRP療法の使用を加速しています。さらに、変形性関節症、腱損傷、脱毛などの慢性疾患の有病率の増加は、しばしば高齢化人口とライフスタイルの変化に関連しており、PRPの需要をさらに煽っています。PRPはさらに組織の再生と治癒を促進するため、臨床と美容の両方の用途で貴重なツールとなっています。

皮膚のボリューム、色調、質感を高めるために、形成外科医や皮膚科医によるPRP治療の採用が増加していることが、市場の成長に大きく寄与しています。2023年の低侵襲手術のトップとして、米国形成外科学会は米国だけで約590万件の再建手術を報告しています。

多血小板血漿市場：分析概要

種類別では、純粋多血小板血漿（P-PRP）または乏白血球・多血小板血漿セグメントが、2024年の多血小板血漿市場シェアを独占しました。これは、リスクや副作用を最小限に抑え、治療中のアレルギーや免疫反応に関連する懸念を軽減するという明確な利点があるためです。

用途別では、皮膚科分野が2024年に最大のシェアを占めました。この急成長の背景には、皮膚の若返り、ニキビ跡治療、毛髪再生など、外科手術を伴わない美容整形に対する需要の高まりがあります。美容治療に対する意識の高まりと、肌の質感や育毛を改善するためのPRPの人気の高まりが、この成長に大きく寄与しました。皮膚科医は、多様な皮膚状態に対処するためにPRPを使用し、治療の選択肢を広げています。

北米は2024年に世界の多血小板血漿市場の収益シェアを独占しました。この市場の主な原動力は、美容外科手術の需要増加、整形外科手術の高い普及率、スポーツ関連傷害の発生率上昇です。さらに、マイクロニードルは、皮膚の若返りという本来の用途に加え、経皮的薬剤投与などさまざまな用途で人気を集めています。

欧州の多血小板血漿市場は、筋骨格系損傷の治療にPRP療法が広く採用されていることから、大きな成長を遂げています。アキレス腱症、足底筋膜炎、テニス肘などの動向が特にこの増加傾向に寄与しています。

世界の主要企業は、Vivostat;Arthrex Inc.;RegenOrthoSport;Dr. PRP USA LLC;Juventix Regenerative Medical, LLC;Terumo Cardiovascular Systems Corporation;Zimmer Biomet;Isto Biologics;Apex Biologix;and Regen Lab SA.などです。

多血小板血漿（PRP）：業界の概要
バリューチェーン分析
- 多血小板血漿（PRP）市場力学
- 促進要因と機会
  - 美容外科と皮膚科におけるPRPの需要増加
  - 高齢者人口の増加、整形外・スポーツ傷害の発生率の増加による、予測期間中のPRP需要の加速
- 抑制要因と課題
  - PRP療法の高額な費用と償還ポリシーの欠如により、市場の成長を妨げる可能性
ポーターのファイブフォース分析
- 代替品の脅威：（低～中）
- 新規参入業者の脅威：（中～高）
- 買い手の交渉力：（低～中）
- 供給企業の交渉力：（中～高）
- 競争企業間の敵対関係：（中～高）
PESTLE分析
COVID-19の影響分析と業界動向

第5章多血小板血漿市場の評価：種類別

主な分析結果
純粋多血小板血漿（P-PRP）
白血球・血小板濃縮血漿（L-PRP）
純粋多血小板フィブリン（P-PRF）
多白血球・多血小板フィブリン（L-PRF）

第6章多血小板血漿（PRP）市場の評価：用途別

イントロダクション
整形外科
スポーツ医学
一般外科
皮膚科
眼科
神経学
心臓病
その他

第7章多血小板血漿（PRP）市場の評価：最終用途別

イントロダクション
病院
クリニック
その他

第8章多血小板血漿（PRP）市場の評価：地域別

イントロダクション
北米
- 北米の多血小板血漿（PRP）市場：種類別
- 北米の多血小板血漿（PRP）市場：用途別
- 最終用途別
- 米国
- カナダ
欧州
- 欧州の多血小板血漿（PRP）市場：種類別
- 欧州の多血小板血漿（PRP）市場：用途別
- 最終用途別
- フランス
- ドイツ
- 英国
- イタリア
- オランダ
- スペイン
- ロシア
- その他欧州
アジア太平洋
- アジア太平洋の多血小板血漿（PRP）市場：種類別
- アジア太平洋の多血小板血漿（PRP）市場：用途別
- 最終用途別
- 日本
- 中国
- インド
- マレーシア
- インドネシア
- 韓国
- オーストラリア
- その他アジア太平洋
ラテンアメリカ
- ラテンアメリカの多血小板血漿（PRP）市場：種類別
- ラテンアメリカの多血小板血漿（PRP）市場：用途別
- 最終用途別
- メキシコ
- ブラジル
- アルゼンチン
- その他ラテンアメリカ
中東・アフリカ
- 中東・アフリカの多血小板血漿（PRP）市場：種類別
- 中東・アフリカの多血小板血漿（PRP）市場：用途別
- 最終用途別
- サウジアラビア
- 南アフリカ
- その他中東・アフリカ

第9章競合情勢

市場の主要企業：分類
戦略的枠組み
ベンダー情勢
戦略の分類
- 発売/承認/開発

第10章企業プロファイル

Vivostat
Arthrex, Inc.
RegenOrthoSport
Dr PRP USA LLC
Juventix Regenerative Medical, LLC.
Terumo Cardiovascular Systems Corporation
Zimmer Biomet
Isto Biologics
APEX Biologix
Regen Lab SA

図表

List of Tables

Table 1 Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 2 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Plasma (P-PRP), 2021 - 2034 (USD Million)
Table 3 Platelet Rich Plasma (PRP) Market, By Leukocyte-and Platelet-Rich Plasma (L-PRP), 2021 - 2034 (USD Million)
Table 4 Platelet Rich Plasma (PRP) Market, By Pure Platelet-Rich Fibrin (P-PRF), 2021 - 2034 (USD Million)
Table 5 Platelet Rich Plasma (PRP) Market, By Leukocyte- and Platelet-Rich Fibrin (L-PRF), 2021 - 2034 (USD Million)
Table 6 Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 7 Platelet Rich Plasma (PRP) Market, By Orthopedics, 2021 - 2034 (USD Million)
Table 8 Platelet Rich Plasma (PRP) Market, By Sports Medicine, 2021 - 2034 (USD Million)
Table 9 Platelet Rich Plasma (PRP) Market, By General Surgery, 2021 - 2034 (USD Million)
Table 10 Platelet Rich Plasma (PRP) Market, By Dermatology, 2021 - 2034 (USD Million)
Table 11 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2021 - 2034 (USD Million)
Table 12 Platelet Rich Plasma (PRP) Market, By Ophthalmology, 2021 - 2034 (USD Million)
Table 13 Platelet Rich Plasma (PRP) Market, By Cardiology, 2021 - 2034 (USD Million)
Table 14 Platelet Rich Plasma (PRP) Market, By Others, 2021 - 2034 (USD Million)
Table 15 Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 16 Platelet Rich Plasma (PRP) Market, By Hospitals, 2021 - 2034 (USD Million)
Table 17 Platelet Rich Plasma (PRP) Market, By Clinics, 2021 - 2034 (USD Million)
Table 18 Platelet Rich Plasma (PRP) Market, By Others, 2021 - 2034 (USD Million)
Table 19 Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2021 - 2034 (USD Million)
Table 20 North America Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 21 North America Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 22 North America Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 23 U.S. Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 24 U.S. Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 25 U.S. Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 26 Canada Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 27 Canada Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 28 Canada Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 29 Europe Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 30 Europe Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 31 Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 32 France Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 33 France Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 34 France Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 35 Germany Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 36 Germany Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 37 Germany Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 38 UK Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 39 UK Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 40 UK Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 41 Italy Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 42 Italy Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 43 Italy Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 44 Netherlands Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 45 Netherlands Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 46 Netherlands Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 47 Spain Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 48 Spain Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 49 Spain Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 50 Russia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 51 Russia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 52 Russia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 53 Rest of Europe Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 54 Rest of Europe Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 55 Rest of Europe Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 56 Asia Pacific Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 57 Asia Pacific Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 58 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 59 Japan Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 60 Japan Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 61 Japan Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 62 China Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 63 China Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 64 China Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 65 India Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 66 India Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 67 India Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 68 Malaysia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 69 Malaysia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 70 Malaysia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 71 Indonesia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 72 Indonesia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 73 Indonesia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 74 South Korea Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 75 South Korea Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 76 South Korea Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 77 Australia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 78 Australia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 79 Australia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 80 Rest of APAC Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 81 Rest of APAC Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 82 Rest of APAC Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 83 Latin America Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 84 Latin America Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 85 Latin America Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 86 Mexico Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 87 Mexico Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 88 Mexico Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 89 Brazil Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 90 Brazil Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 91 Brazil Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 92 Argentina Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 93 Argentina Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 94 Argentina Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 95 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 96 Rest of LATAM Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 97 Rest of LATAM Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 98 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 99 Middle East & Africa Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 100 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 101 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 102 Saudi Arabia Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 103 Saudi Arabia Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 104 South Africa Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 105 South Africa Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 106 South Africa Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)
Table 107 Rest of MEA Platelet Rich Plasma (PRP) Market, By Type, 2021 - 2034 (USD Million)
Table 108 Rest of MEA Platelet Rich Plasma (PRP) Market, By Application, 2021 - 2034 (USD Million)
Table 109 Rest of MEA Platelet Rich Plasma (PRP) Market, By End-Use, 2021 - 2034 (USD Million)

List of Figures

Figure 1. Information Procurement
Figure 2. Primary Research Pattern
Figure 3. Primary research process
Figure 4. Market research approaches - Bottom-Up Approach
Figure 5. Market research approaches - Top-Down Approach
Figure 6. Market research approaches - Combined Approach
Figure 7. Executive Summary
Figure 8. Market by Region, 2022 (USD Million)
Figure 9. Platelet Rich Plasma (PRP) Market, 2021 - 2034 (USD Million)
Figure 10. Value Chain Analysis
Figure 11. Porter's Five Forces
Figure 12. PESTLE Analysis
Figure 13. Market by Type
Figure 14. Platelet Rich Plasma (PRP) Market, By Type, 2024 & 2034 (USD Million)
Figure 15. Market by Application
Figure 16. Platelet Rich Plasma (PRP) Market, By Application, 2024 & 2034 (USD Million)
Figure 17. Market by End-Use
Figure 18. Platelet Rich Plasma (PRP) Market, By End-Use, 2024 & 2034 (USD Million)
Figure 19. Platelet Rich Plasma (PRP) Market Assessment, By Geography, 2024 & 2034 (USD Million)

Product Code: PM5030

The global platelet rich plasma (PRP) market size is expected to reach USD 2,857.98 million by 2034, according to a new study by Polaris Market Research. The report "Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

Platelet rich plasma (PRP) is a key component in the field of regenerative medicine and therapeutic treatments, significantly transforming approaches in tissue repair and healing. Derived from a patient's own blood, PRP offers several advantages over conventional treatment methods, such as reduced risk of allergic reactions and faster recovery times. The growing demand for PRP is fueled by its safety, effectiveness, and natural healing properties, making it an increasingly preferred option across orthopedics, dermatology, sports medicine, and medical aesthetic procedures.

The PRP market is expanding rapidly due to ongoing scientific advancements and increasing demand in real world clinical settings. Government worldwide is supporting regenerative medicine through funding, research grants, and favorable regulations which is encouraging the development and adoption of PRP based treatments. Therefore, these factors have accelerated the usage of PRP therapies in areas such as tissue repair and musculoskeletal healing. Additionally, the growing prevalence of chronic conditions such as osteoarthritis, tendon injuries, and hair loss, which are often linked to aging populations and lifestyle changes, is further fueling demand for PRP. PRP further promotes tissue regeneration and healing, making it a valuable tool in both clinical and cosmetic applications.

The growing adoption of PRP treatments by plastic surgeons and dermatologists to enhance skin volume, tone, and texture has contributed significantly to the growth of the market. As the top minimally invasive procedure of 2023, the American Society of Plastic Surgeons reported nearly 5.9 million reconstructive procedures in the US alone.

Platelet Rich Plasma Market Report Highlights

Based on type, the pure platelet-rich plasma (P-PRP) or leukocyte-poor platelet-rich plasma segment dominated the platelet rich plasma market share in 2024, due to its distinct advantage with minimal risk and adverse effects, reducing concerns related to allergies and immune responses during treatments.

By application, the dermatology segment accounted for the largest share in 2024. The rapid growth is attributed to the growing demand for nonsurgical cosmetic surgery, such as skin rejuvenation, acne scar treatment, and hair restoration. Increased awareness of aesthetic treatments and the rising popularity of PRP for improving skin texture and hair growth significantly contributed to this growth. Dermatologists are using PRP to address diverse skin conditions, expanding treatment options.

North America dominated the global platelet rich plasma market revenue share in 2024. This market is primarily driven by increasing demand for cosmetic surgeries, a high prevalence of orthopedic procedures, and a rising incidence of sports-related injuries. Furthermore, micro-needling is gaining popularity for various applications, including transcutaneous drug administration, in addition to its original intended use for skin rejuvenation.

The platelet rich plasma market in Europe is experiencing significant growth, owing to the widespread adoption of PRP therapy for the treatment of musculoskeletal injuries. Conditions such as Achilles tendinopathy, plantar fasciitis, and tennis elbow are particularly contributing to this upward trend.

A few global key market players are Vivostat; Arthrex Inc.; RegenOrthoSport; Dr. PRP USA LLC; Juventix Regenerative Medical, LLC; Terumo Cardiovascular Systems Corporation; Zimmer Biomet; Isto Biologics; Apex Biologix; and Regen Lab SA.

Polaris Market Research has segmented the platelet rich plasma market report on the basis of type, application, end use, and region:

By Type Outlook (Revenue, USD Million, 2020-2034)

Pure Platelet-Rich Plasma (P-PRP)

Leukocyte-and Platelet-Rich Plasma (L-PRP)

Pure Platelet-Rich Fibrin (P-PRF) - or Leukocyte-Poor Platelet-Rich Fibrin

Leukocyte- and Platelet-Rich Fibrin (L-PRF)

By Application Outlook (Revenue, USD Million, 2020-2034)

Orthopedics

Sports Medicine

General Surgery

Dermatology

Ophthalmology

Neurology

Cardiology

Others

By End Use Outlook (Revenue, USD Million, 2020-2034)

Hospitals

Clinics

Others

By Regional Outlook (Revenue, USD Million, 2020-2034)

North America

Canada

Mexico

Europe

Germany

France

Italy

Spain

Netherlands

Russia

Rest of Europe

Asia Pacific

China

Japan

India

South Korea

Malaysia

Australia

Indonesia

Rest of Asia Pacific

Middle East & Africa

Saudi Arabia

UAE

Israel

Rest of Middle East & Africa

Latin America

Brazil

Argentina

Rest of Latin America

Chapter 1. Introduction

1.1 Report Description
- 1.1.1 Objective of the Study
- 1.1.2 Market Scope
- 1.1.3 Assumptions
1.2 Stakeholders

Chapter 2. Research Methodology

2.1 Research Methodology
2.2 Research Scope and Assumptions
2.3 Information Procurement
- 2.3.1 Purchased Database
- 2.3.2 Internal Database
- 2.3.3 Secondary Sources
- 2.3.4 Third Party Perspective
- 2.3.5 Primary Research
2.4 Information Analysis
- 2.4.1 Data Analysis Models
2.5 Market Formulation and Data Visualization
2.6 Data Validation and Publishing (Secondary Sources)

Chapter 3. Executive Summary

Chapter 4. Market Insights

4.1 Platelet Rich Plasma (PRP) - Industry snapshot
4.2 Platelet Rich Plasma (PRP) Market - Value Chain Analysis
- 4.2.1 Platelet Rich Plasma (PRP) Market Dynamics
- 4.2.2 Drivers and Opportunities
  - 4.2.2.1 Rise in demand of PRP in cosmetic surgeries and dermatology
  - 4.2.2.2 Increasing geriatric population, and rise in the occurrence of orthopaedic and sports injuries accelerate the PRP demand over the forecast period
- 4.2.3 Restraints and Challenges
  - 4.2.3.1 High cost of PRP therapy and lack of reimbursement policy may hamper the market growth
4.3 Platelet Rich Plasma (PRP) Market - Porter's Five Forces
- 4.3.1 Threat of Substitutes: (Low to Moderate)
- 4.3.2 Threat of New Entrants: (Moderate to high)
- 4.3.3 Bargaining power of buyers: (Low to Moderate)
- 4.3.4 Bargaining power of suppliers: (Moderate to High)
- 4.3.5 Competitive Rivalry: (Moderate to High)
4.4 Platelet Rich Plasma (PRP) Market - PESTLE Analysis
4.5 Covid-19 Impact Analysis & Industry Trends

Chapter 5. Platelet Rich Plasma (PRP) Market Assessment by Type

5.1 Introduction
5.2 Pure Platelet-Rich Plasma (P-PRP)
5.3 Leukocyte-and Platelet-Rich Plasma (L-PRP)
5.4 Pure Platelet-Rich Fibrin (P-PRF)
5.5 Leukocyte- and Platelet-Rich Fibrin (L-PRF)

Chapter 6. Platelet Rich Plasma (PRP) Market Assessment by Application

6.1 Introduction
6.2 Orthopedics
6.3 Sports Medicine
6.4 General Surgery
6.5 Dermatology
6.6 Ophthalmology
6.7 Neurology
6.8 Cardiology
6.9 Others

Chapter 7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

7.1 Introduction
7.2 Hospitals
7.3 Clinics
7.4 Others

Chapter 8. Platelet Rich Plasma (PRP) Market Assessment by Region

8.1 Introduction
8.2 Platelet Rich Plasma (PRP) Market - North America
- 8.2.1 North America Platelet Rich Plasma (PRP), By Type
- 8.2.2 North America Platelet Rich Plasma (PRP), By Application
- 8.2.3 North America Platelet Rich Plasma (PRP) Market, By End-Use
- 8.2.4 Platelet Rich Plasma (PRP) Market - U.S.
  - 8.2.4.1 U.S. Platelet Rich Plasma (PRP), By Type
  - 8.2.4.2 U.S. Platelet Rich Plasma (PRP), By Application
  - 8.2.4.3 U.S. Platelet Rich Plasma (PRP), By End-Use
- 8.2.5 Platelet Rich Plasma (PRP) Market - Canada
  - 8.2.5.1 Canada Platelet Rich Plasma (PRP), By Type
  - 8.2.5.2 Canada Platelet Rich Plasma (PRP), By Application
  - 8.2.5.3 Canada Platelet Rich Plasma (PRP), By End-Use
8.3 Platelet Rich Plasma (PRP) Market - Europe
- 8.3.1 Europe Platelet Rich Plasma (PRP), By Type
- 8.3.2 Europe Platelet Rich Plasma (PRP), By Application
- 8.3.3 Europe Platelet Rich Plasma (PRP) Market, By End-Use
- 8.3.4 Platelet Rich Plasma (PRP) Market - France
  - 8.3.4.1 France Platelet Rich Plasma (PRP), By Type
  - 8.3.4.2 France Platelet Rich Plasma (PRP), By Application
  - 8.3.4.3 France Platelet Rich Plasma (PRP), By End-Use
- 8.3.5 Platelet Rich Plasma (PRP) Market - Germany
  - 8.3.5.1 Germany Platelet Rich Plasma (PRP), By Type
  - 8.3.5.2 Germany Platelet Rich Plasma (PRP), By Application
  - 8.3.5.3 Germany Platelet Rich Plasma (PRP), By End-Use
- 8.3.6 Platelet Rich Plasma (PRP) Market - UK
  - 8.3.6.1 UK Platelet Rich Plasma (PRP), By Type
  - 8.3.6.2 UK Platelet Rich Plasma (PRP), By Application
  - 8.3.6.3 UK Platelet Rich Plasma (PRP), By End-Use
- 8.3.7 Platelet Rich Plasma (PRP) Market - Italy
  - 8.3.7.1 Italy Platelet Rich Plasma (PRP), By Type
  - 8.3.7.2 Italy Platelet Rich Plasma (PRP), By Application
  - 8.3.7.3 Italy Platelet Rich Plasma (PRP), By End-Use
- 8.3.8 Platelet Rich Plasma (PRP) Market - Netherlands
  - 8.3.8.1 Netherlands Platelet Rich Plasma (PRP), By Type
  - 8.3.8.2 Netherlands Platelet Rich Plasma (PRP), By Application
  - 8.3.8.3 Netherlands Platelet Rich Plasma (PRP), By End-Use
- 8.3.9 Platelet Rich Plasma (PRP) Market - Spain
  - 8.3.9.1 Spain Platelet Rich Plasma (PRP), By Type
  - 8.3.9.2 Spain Platelet Rich Plasma (PRP), By Application
  - 8.3.9.3 Spain Platelet Rich Plasma (PRP), By End-Use
- 8.3.10 Platelet Rich Plasma (PRP) Market - Russia
  - 8.3.10.1 Russia Platelet Rich Plasma (PRP), By Type
  - 8.3.10.2 Russia Platelet Rich Plasma (PRP), By Application
  - 8.3.10.3 Russia Platelet Rich Plasma (PRP), By End-Use
- 8.3.11 Platelet Rich Plasma (PRP) Market - Rest of Europe
  - 8.3.11.1 Rest of Europe Platelet Rich Plasma (PRP), By Type
  - 8.3.11.2 Rest of Europe Platelet Rich Plasma (PRP), By Application
  - 8.3.11.3 Rest of Europe Platelet Rich Plasma (PRP), By End-Use
8.4 Platelet Rich Plasma (PRP) Market - Asia Pacific
- 8.4.1 Asia Pacific Platelet Rich Plasma (PRP), By Type
- 8.4.2 Asia Pacific Platelet Rich Plasma (PRP), By Application
- 8.4.3 Asia Pacific Platelet Rich Plasma (PRP) Market, By End-Use
- 8.4.4 Platelet Rich Plasma (PRP) Market - Japan
  - 8.4.4.1 Japan Platelet Rich Plasma (PRP), By Type
  - 8.4.4.2 Japan Platelet Rich Plasma (PRP), By Application
  - 8.4.4.3 Japan Platelet Rich Plasma (PRP), By End-Use
- 8.4.5 Platelet Rich Plasma (PRP) Market - China
  - 8.4.5.1 China Platelet Rich Plasma (PRP), By Type
  - 8.4.5.2 China Platelet Rich Plasma (PRP), By Application
  - 8.4.5.3 China Platelet Rich Plasma (PRP), By End-Use
- 8.4.6 Platelet Rich Plasma (PRP) Market - India
  - 8.4.6.1 India Platelet Rich Plasma (PRP), By Type
  - 8.4.6.2 India Platelet Rich Plasma (PRP), By Application
  - 8.4.6.3 India Platelet Rich Plasma (PRP), By End-Use
- 8.4.7 Platelet Rich Plasma (PRP) Market - Malaysia
  - 8.4.7.1 Malaysia Platelet Rich Plasma (PRP), By Type
  - 8.4.7.2 Malaysia Platelet Rich Plasma (PRP), By Application
  - 8.4.7.3 Malaysia Platelet Rich Plasma (PRP), By End-Use
- 8.4.8 Platelet Rich Plasma (PRP) Market - Indonesia
  - 8.4.8.1 Indonesia Platelet Rich Plasma (PRP), By Type
  - 8.4.8.2 Indonesia Platelet Rich Plasma (PRP), By Application
  - 8.4.8.3 Indonesia Platelet Rich Plasma (PRP), By End-Use
- 8.4.9 Platelet Rich Plasma (PRP) Market - South Korea
  - 8.4.9.1 South Korea Platelet Rich Plasma (PRP), By Type
  - 8.4.9.2 South Korea Platelet Rich Plasma (PRP), By Application
  - 8.4.9.3 South Korea Platelet Rich Plasma (PRP), By End-Use
- 8.4.10 Platelet Rich Plasma (PRP) Market - Australia
  - 8.4.10.1 Australia Platelet Rich Plasma (PRP), By Type
  - 8.4.10.2 Australia Platelet Rich Plasma (PRP), By Application
  - 8.4.10.3 Australia Platelet Rich Plasma (PRP), By End-Use
- 8.4.11 Platelet Rich Plasma (PRP) Market - Rest of APAC
  - 8.4.11.1 Rest of APAC Platelet Rich Plasma (PRP), By Type
  - 8.4.11.2 Rest of APAC Platelet Rich Plasma (PRP), By Application
  - 8.4.11.3 Rest of APAC Platelet Rich Plasma (PRP), By End-Use
8.5 Platelet Rich Plasma (PRP) Market - Latin America
- 8.5.1 Latin America Platelet Rich Plasma (PRP), By Type
- 8.5.2 Latin America Platelet Rich Plasma (PRP), By Application
- 8.5.3 Latin America Platelet Rich Plasma (PRP) Market, By End-Use
- 8.5.4 Platelet Rich Plasma (PRP) Market - Mexico
  - 8.5.4.1 Mexico Platelet Rich Plasma (PRP), By Type
  - 8.5.4.2 Mexico Platelet Rich Plasma (PRP), By Application
  - 8.5.4.3 Mexico Platelet Rich Plasma (PRP), By End-Use
- 8.5.5 Platelet Rich Plasma (PRP) Market - Brazil
  - 8.5.5.1 Brazil Platelet Rich Plasma (PRP), By Type
  - 8.5.5.2 Brazil Platelet Rich Plasma (PRP), By Application
  - 8.5.5.3 Brazil Platelet Rich Plasma (PRP), By End-Use
- 8.5.6 Platelet Rich Plasma (PRP) Market - Argentina
  - 8.5.6.1 Argentina Platelet Rich Plasma (PRP), By Type
  - 8.5.6.2 Argentina Platelet Rich Plasma (PRP), By Application
  - 8.5.6.3 Argentina Platelet Rich Plasma (PRP), By End-Use
- 8.5.7 Platelet Rich Plasma (PRP) Market - Rest of Latin America
  - 8.5.7.1 Rest of LATAM Platelet Rich Plasma (PRP), By Type
  - 8.5.7.2 Rest of LATAM Platelet Rich Plasma (PRP), By Application
  - 8.5.7.3 Rest of LATAM Platelet Rich Plasma (PRP), By End-Use
8.6 Platelet Rich Plasma (PRP) Market - Middle East Africa
- 8.6.1 Middle East & Africa Platelet Rich Plasma (PRP), By Type
- 8.6.2 Middle East & Africa Platelet Rich Plasma (PRP), By Application
- 8.6.3 Middle East & Africa Platelet Rich Plasma (PRP) Market, By End-Use
- 8.6.4 Platelet Rich Plasma (PRP) Market - Saudi Arabia
  - 8.6.4.1 Saudi Arabia Platelet Rich Plasma (PRP), By Type
  - 8.6.4.2 Saudi Arabia Platelet Rich Plasma (PRP), By Application
  - 8.6.4.3 Saudi Arabia Platelet Rich Plasma (PRP), By End-Use
- 8.6.5 Platelet Rich Plasma (PRP) Market - South Africa
  - 8.6.5.1 South Africa Platelet Rich Plasma (PRP), By Type
  - 8.6.5.2 South Africa Platelet Rich Plasma (PRP), By Application
  - 8.6.5.3 South Africa Platelet Rich Plasma (PRP), By End-Use
- 8.6.6 Platelet Rich Plasma (PRP) Market - Rest of MEA
  - 8.6.6.1 Rest of MEA Platelet Rich Plasma (PRP), By Type
  - 8.6.6.2 Rest of MEA Platelet Rich Plasma (PRP), By Application
  - 8.6.6.3 Rest of MEA Platelet Rich Plasma (PRP), By End-Use

Chapter 9. Competitive Landscape

9.1 Key Market Players: Categorization
9.2 Strategy Framework
9.3 Vendor Landscape
9.4 Strategies Categorization
- 9.4.1 Launch/Approval/Development

Chapter 10. Company Profiles

10.1 Vivostat
- 10.1.1 Business Overview
- 10.1.2 Products and Services
10.2 Arthrex, Inc.
- 10.2.1 Business Overview
- 10.2.2 Products and Services
- 10.2.3 Recent Developments
10.3 RegenOrthoSport
- 10.3.1 Business Overview
- 10.3.2 Products and Services
10.4 Dr PRP USA LLC
- 10.4.1 Business Overview
- 10.4.2 Products and Services
10.5 Juventix Regenerative Medical, LLC.
- 10.5.1 Business Overview
- 10.5.2 Products and Services
10.6 Terumo Cardiovascular Systems Corporation
- 10.6.1 Business Overview
- 10.6.2 Financial Snapshot
  - 10.6.2.1 Revenue by Geographic Region
- 10.6.3 Products and Services
10.7 Zimmer Biomet
- 10.7.1 Business Overview
- 10.7.2 Financial Snapshot
  - 10.7.2.1 Net Sales by Geographic
  - 10.7.2.2 Net Sales by Product Category
- 10.7.3 Products and Services
- 10.7.4 Recent Developments
10.8 Isto Biologics
- 10.8.1 Business Overview
- 10.8.2 Products and Services
- 10.8.3 Recent Developments
10.9 APEX Biologix
- 10.9.1 Business Overview
- 10.9.2 Products and Services
- 10.9.3 Recent Developments
10.10 Regen Lab SA
- 10.10.1 Business Overview
- 10.10.2 Products and Services

多血小板血漿（PRP）の世界市場：市場規模・シェア・動向、業界分析 (種類別・用途別・最終用途別・地域別)、将来予測 (2025年～2034年)

Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034

多血小板血漿市場：分析概要

目次

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章市場洞察

第5章多血小板血漿市場の評価：種類別

第6章多血小板血漿（PRP）市場の評価：用途別

第7章多血小板血漿（PRP）市場の評価：最終用途別

第8章多血小板血漿（PRP）市場の評価：地域別

第9章競合情勢

第10章企業プロファイル

List of Tables

List of Figures

Platelet Rich Plasma Market Report Highlights

Table of Contents

Chapter 1. Introduction

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Insights

Chapter 5. Platelet Rich Plasma (PRP) Market Assessment by Type

Chapter 6. Platelet Rich Plasma (PRP) Market Assessment by Application

Chapter 7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

Chapter 8. Platelet Rich Plasma (PRP) Market Assessment by Region

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

多血小板血漿（PRP）の世界市場：市場規模・シェア・動向、業界分析 (種類別・用途別・最終用途別・地域別)、将来予測 (2025年～2034年)

Platelet Rich Plasma (PRP) Market Size, Share, Trends, & Industry Analysis Report By Type (Pure, Leukocyte, Pure Platelet-Rich Fibrin), By Application, By End Use, By Region - Market Forecast, 2025-2034

多血小板血漿市場：分析概要

目次

第1章 イントロダクション

第2章 エグゼクティブサマリー

第3章 分析手法

第4章 市場洞察

第5章 多血小板血漿市場の評価：種類別

第6章 多血小板血漿（PRP）市場の評価：用途別

第7章 多血小板血漿（PRP）市場の評価：最終用途別

第8章 多血小板血漿（PRP）市場の評価：地域別

第9章 競合情勢

第10章 企業プロファイル

List of Tables

List of Figures

Platelet Rich Plasma Market Report Highlights

Table of Contents

Chapter 1. Introduction

Chapter 2. Research Methodology

Chapter 3. Executive Summary

Chapter 4. Market Insights

Chapter 5. Platelet Rich Plasma (PRP) Market Assessment by Type

Chapter 6. Platelet Rich Plasma (PRP) Market Assessment by Application

Chapter 7. Platelet Rich Plasma (PRP) Market Assessment by End-Use

Chapter 8. Platelet Rich Plasma (PRP) Market Assessment by Region

Chapter 9. Competitive Landscape

Chapter 10. Company Profiles

第1章イントロダクション

第2章エグゼクティブサマリー

第3章分析手法

第4章市場洞察

第5章多血小板血漿市場の評価：種類別

第6章多血小板血漿（PRP）市場の評価：用途別

第7章多血小板血漿（PRP）市場の評価：最終用途別

第8章多血小板血漿（PRP）市場の評価：地域別

第9章競合情勢

第10章企業プロファイル